RVTY — REVVITY, INC.
—
NYSE ·
Unknown ·
Unknown ·
CIK 31791 ·
Last close
$151.11
Market Cap
$16.86B
52W High
$152.26
52W Low
$81.17
ADV30
1,943,390
Next earnings
2026-10-26
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | — | — | — | — | — | — | — |
| Dec 2025 | 772,056,000 | 421,659,000 | 111,749,000 | 98,364,000 | 12,168,411,000 | 919,860,000 | 4,918,051,000 |
| Sep 2025 | 698,949,000 | 374,604,000 | 81,896,000 | 46,652,000 | 12,138,952,000 | 931,386,000 | 4,763,056,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$580,746,000
Investing CF
$-136,122,000
Financing CF
$-782,754,000
CapEx
$-77,315,000
Dividends Paid
$-32,207,000
Buybacks
$-753,717,000
EPS Diluted TTM
$2.09
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$6,087,222,000
Inventory
$387,505,000
Receivables
$691,380,000
ST Investments
$0
EBIT TTM
$359,826,000
Pretax Income TTM
$265,887,000
Interest Exp TTM
$93,939,000
Analysts
15
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,911,811,072
EBITDA
$875,832,000
Free Cash Flow
$604,992,128
Enterprise Value
$16,189,878,272
Total Cash
$1,022,942,976
Total Debt
$3,341,516,032
Shares Out
111,586,401
Trailing EPS
$2.08
Book Value
$64.78
ROE
3.2%
ROA
2.4%
Div Yield
0.23%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,856,051,000 | 356,635,000 | 241,201,000 | 12,168,411,000 | 4,918,051,000 | 7,250,360,000 | 582,933,000 |
| Dec 2024 | 2,755,026,000 | 346,741,000 | 270,385,000 | 12,392,478,000 | 4,725,604,000 | 7,666,874,000 | 628,299,000 |
| Dec 2023 | 2,750,571,000 | 300,562,000 | 693,094,000 | 13,564,665,000 | 5,691,926,000 | 7,872,739,000 | 91,272,000 |
| Dec 2022 | 3,311,822,000 | 742,699,000 | 569,179,000 | 14,129,855,000 | 6,746,979,000 | 7,382,876,000 | 679,810,000 |
TTM Snapshot
Revenues TTM
$2,731,353,000
NetIncome TTM
$231,448,000
OpCashFlow TTM
$0
Assets (Latest)
$12,168,411,000
Forward EPS
$5.89
Max Pain — expiry 2026-11-20
max pain strike: $145.00 · spot: $148.38 · call oi: 2,166 · put oi: 16
Expected Move to 2026-11-20:
±$21.05
(14.19%) —
implied range
$127.33 –
$169.43
· ATM straddle on $150.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| FTV | Fortive Corp | $16.94B | $56.09 | — |
| ARNNY | ASR Nederland N.V./ADR | $17.05B | $42.30 | — |
| BKZHF | Santander Bank Polska SA/ADR | $17.06B | $166.92 | — |
| PAA | PLAINS ALL AMERICAN PIPELINE LP | $17.23B | $24.42 | — |
| DSEEY | Daiwa Securities Group Inc. | $16.50B | $11.88 | — |
News headlines (Yahoo Finance, 1h cache)
RVTY Launches New Kit in Europe for Newborn Type 1 Diabetes Detection
2026-09-25 13:09 · Yahoo
Revvity Launches IVDR-Certified Solution for Early Detection of Type 1 Diabetes
2026-09-24 12:00 · Yahoo
Is Revvity Stock Outperforming the Dow?
2026-09-23 10:33 · Yahoo
Why Revvity (RVTY) Is Getting Attention Today
2026-09-23 02:12 · Yahoo
Q2 Rundown: Revvity (NYSE:RVTY) Vs Other Research Tools & Consumables Stocks
2026-09-15 13:35 · Yahoo
Revvity to Acquire Human Cell Design to Advance Human-Relevant Cell Models for Metabolic Disease Drug Discovery
2026-09-09 10:00 · Yahoo
Is Revvity Stock a Buy as Growth Improves but Valuation Stays Rich?
2026-09-04 11:49 · Yahoo
Revvity (RVTY) Stock Looks Fair On Cash Flow Yet Pricey On Earnings
2026-09-03 02:14 · Yahoo
Research Use Recombinant Protein Market Report Now Available — Forecasts Market Growth from $1.11B (2026) to $1.55B by 2031, Profiling Thermo Fisher, Bio-Techne, Merck KGaA, Danaher, Revvity, and Othe
2026-09-08 14:49 · Yahoo
1 Unpopular Stock That Deserves Some Love and 2 Facing Headwinds
2026-09-28 09:02 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.